AndhraNews.net
Home » Business News » 2011 » June » June 4

Business News on June 4, 2011


Archives exhibition showcases history of Assam
In an endeavor to spread awareness among students and scholars about archives, Assam recently hosted its annual archive week showcasing important historical artifacts. ANI

SciClone Presents New Preclinical Data Highlighting Potential Role of SCV-07 in Cancer Treatment at 2011 ASCO Annual Meeting
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) ("Company") today announced new data from preclinical studies of SCV-07, the Company's lead development product candidate, which showed that the compound successfully inhibited the growth of a variety of tumor cell lines in mice MarketWire

Brunei School Wins Project Earth 2011 World Environment Day Contest
Ecology and Environment, Inc. (E & E) (NASDAQ: EEI) is proud to announce the Project Earth 2011 World Environment Day Contest project winners, selected from nearly 400 entries received from schools around the world. MarketWire

Direct Selling Executives From Around the World Show "Y We Care" About Miami-Dade's Teens and Tweens
When hundreds of company executives gather in Miami for the 2011 annual convention of the Direct Selling Association, they will do more than take in the Florida sunshine and discuss their direct selling businesses. On June 5th, from 8:00 a.m. to 12:00 p.m MarketWire

Free Community Lecture on Keeping Pets Safe From Desert Dangers to Be Held at Veterinary Specialty Center of Tucson on June 29th
As part of their monthly Community Pet Lecture Series, the Veterinary Specialty Center of Tucson will be hosting a free June 29th lecture on keeping your pets safe from desert dangers such as: MarketWire

TradeTech Uranium Spot Price Stabilizes Amid Market Uncertainty
TradeTech's uranium spot price fluctuated throughout May, which did not discourage buyers or sellers as market activity soared, with 33 deals moving nearly 4 million pounds uranium oxide (U3O8) equivalent during the month. MarketWire

Novartis JAK inhibitor INC424 shows significant clinical benefit for myelofibrosis patients in two Phase III studies at ASCO
Novartis International AG /Novartis JAK inhibitor INC424 shows significant clinical benefit for myelofibrosis patients in two Phase III studies at ASCO . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement. GlobeNewswire

Comment on this story

Share